(Vir)alteration of investor optimism

Financial markets staged a strong start to the new year, propelled by the ‘phase one’ US/China trade agreement. And yet, a new spectre has caught the markets. The confirmation of human-to-human transmission of the Coronavirus on Jan. 20 and a first US case a day later caused risk sell-off in the second half of January.

Highlights:

  • Just as the trade truce provided broad-based relief, the Coronavirus is unsettling global markets.
  • The fast-spreading disease is challenging the tender global macro green shoots, but we still see resilience in US and EA domestic demand.
  • Experience from past episodes suggests that markets tend to overshoot, but rebound sharply once the number of new infections starts to slow.
  • Even before the Coronavirus, we had embraced a slightly more cautious stance on early signs of investor complacency. We maintain a (smaller) prorisk tilt in the portfolios, but reduce overweights in Equities and HY Credit. We keep our overweight in IG corporates and underweight in core bonds.

Download the full publication below

(VIR)ALTERATION OF
INVESTOR OPTIMISM

RELATED INSIGHTS

COVID-19 FACTS & FIGURES
Sanofi and GSK are in advanced discussion with the European Commission to supply up to 300 million doses of an experimental Covid-19 vaccine.
GLOBAL VIEW – ENJOY SUMMER WHILE IT LASTS
As lockdowns have been lifted and global activity rebounded from the Q2 nadir, hopes of a strong recovery have helped risk assets advance further over July.
Generali Investments among preferred asset managers brands in Europe
We are pleased to share with you the outcome of the first survey on “Preferred Asset Management Firms by European fund selectors” run by Cerulli Associates, in which Generali Investments ranked #11.